GATA5 and hepatocellular carcinoma: The results indicated that clinical HCC tissues expressed lower levels of GATA5 but higher levels of β‐catenin and reprogramming genes p‐Oct4, Nanog, Klf4, c‐myc and EpCAM than normal liver tissues (Figure 1A,B).